Clinical Trials Browser

Phase 4 × durvalumab × CNS × Clear all

NCT04356222 2020-05-27

Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Phase 4 Unknown

Meningeal Carcinomatosis